Leg Men

Stone, Andy
November 2006
Forbes Asia;11/13/2006, Vol. 2 Issue 19, p106
The article focuses on Spectranetics Corp. which has developed the so-called cardiovascular excimer laser. The medical device shoots a powerful beam, up to 2.5 millimeters in diameter, that cuts through cholesterol plaque. Spectranetics CEO John Schulte is in the battle to get his machine into the hands of doctors as quickly as possible. Spectranetics is racing to become the dominant player in the market for treating peripheral artery disease.


Related Articles

  • Spectranetics Announces 1st Patient Enrolled in EXCITE ISR Clinical Trial.  // Biomedical Market Newsletter;7/5/2011, p758 

    The article reports that Spectranetics Corp. has enrolled the first patient in the EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis (EXCITE ISR) clinical trial. It says that the said patient was treated at Community Hospital in Munster, Indiana by...

  • Product pipeline.  // Cardiovascular Devices & Drugs;Jun2008, Vol. 14 Issue 6, p39 

    The article highlights the suggestion of the study "Large, Single-Catheter, Single-Operator Experience With Transvenous Lead Extraction: Outcomes and Changing Indications" that the SLS II excimer laser sheath from Spectranetics is safe and effective to use in removing pacing and defibrillator...

  • Thin-flap LASIK achieves good visual acuity, improves surgical time. Kelly, Andrew // Ocular Surgery News Europe/Asia-Pacific Edition;Aug2008, Vol. 19 Issue 8, p22 

    This article discusses a study that examined laser performance for thin-flap laser-assisted in-situ keratomileusis (LASIK). Both IntraLase FS60 femtosecond laser and excimer laser ablation with the Allegretto Wave Concerto were used in this study. According to Yoshihiro Kitazawa of Kanagawa...

  • Scanning excimer laser looks promising in U.S. myopia trial. Guttman, Cheryl; Weiss, Jayne S. // Ophthalmology Times;04/15/97, Vol. 22 Issue 8, pN48 

    Discusses the outcome of clinical trials for Meditec MEL 60, a scanning excimer laser in the United States. Features; Impact on low and moderate myopia; Average manifest refraction data.

  • Court report.  // Medical Device Daily;4/29/2008, Vol. 12 Issue 83, p2 

    The article reports on the settlement of an intellectual property dispute between Spectranetics and Medtronic. Medtronic has decided to take a license to the patent at issue in the litigation. In a statement issued by John Schulte, Spectranetics president and chief executive officer (CEO), he...

  • Laser Offers a 'CLiR' Solution. Bowe, Wade // Medical Design Technology;Jul2006, Vol. 10 Issue 7, p18 

    The article evaluates the CliRpath line of laser catheter from Spectranetics and offers information on how it treat peripheral arterial disease, what it provides, how it operates, and characteristics.

  • LASIK past and future. Moadel, Ken; Waring, George O. // Ophthalmology Times;7/17/95, Vol. 20 Issue 27, p15 

    Reports on the outcome of excimer laser keratomileusis in situ (LASIK) for the treatment of myopia. History of LASIK's development; Forms of keratomileusis; Transition from photorefractive keratectomy to LASIK; Equipment used in LASIK.

  • Surgeons report complications. Henahan, John // Ophthalmology Times;11/6/95, Vol. 20 Issue 43, p10 

    Reports on the result of a survey of excimer laser use in Europe showing that photorefractive keratectomy (PRK) remains troubled by complications. Increasing number of surgeons who use PRK; Reported postoperative complications; Problems related to delivery and maintenance of excimer lasers;...

  • Excimer laser is good therapy. Sabbagh, Leslie // Ophthalmology Times;2/5/96, Vol. 21 Issue 5, p7 

    Focuses on the use of the excimer laser for the treatment of recurrent corneal epithelial erosions. Other therapeutic uses of the excimer laser; Manual corneal scraping for recurrent erosion; Cost of the excimer treatment; Surgical protocol.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics